Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1995 | 03-1995 | 12-1994 | 09-1994 | 06-1994 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 11,997 | 11,780 | 26,850 | 23,251 | 19,736 |
| TOTAL | $11,997 | $11,780 | $26,850 | $23,251 | $19,736 |
| Non-Current Assets | |||||
| PPE Net | 212,403 | 209,723 | N/A | N/A | 555,681 |
| Investments And Advances | 0 | 4,138 | 6,882 | 9,513 | 12,870 |
| Other Non-Current Assets | 242,828 | 239,947 | 94,424 | 90,764 | 91,049 |
| TOTAL | $455,231 | $453,808 | $101,306 | $100,277 | $659,600 |
| Total Assets | $467,228 | $465,588 | $128,156 | $123,528 | $679,336 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 36,670 | 290 | 3,810 | 76,883 | 57,433 |
| Accounts payable and accrued liabilities | 14,770 | 11,397 | 17,781 | 14,970 | 18,044 |
| Accrued Expenses | 5,931 | 6,267 | 11,024 | 10,667 | 9,195 |
| TOTAL | $72,258 | $35,711 | $39,209 | $109,280 | $94,267 |
| Non-Current Liabilities | |||||
| TOTAL | $59,938 | $59,786 | $137,176 | $133,308 | $133,066 |
| Total Liabilities | $132,196 | $95,497 | $176,385 | $242,588 | $227,333 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 55,539 | 0 | 168,875 |
| Other shareholders' equity | 168,455 | 173,215 | 2,515 | 0 | 0 |
| TOTAL | $168,455 | $173,215 | $103,547 | $N/A | $168,875 |
| Total Liabilities And Equity | $300,651 | $268,712 | $279,932 | $242,588 | $396,208 |